By giving you access to the latest insights, expertise, and altogether different perspectives of our scientific and technical experts at Pfizer, we help you stay up-to-date with the critical developments we encounter across the ever-evolving pharmaceutical landscape.
In the latest podcast with Pharmaceutical Technology, our Senior Manager of Product Development Dr. Martín Gonzales discusses the importance of having access to the specialist support you need to navigate the complex sterile injectable landscape and help deliver high-quality therapeutics to patients.
Navigating the intricate sterile injectable (SI) landscape, supporting the unique needs of your project and delivering high-quality is complex. In this 1-pager we outline how our extensive capabilities, specialized technologies, regulatory expertise, and flexible and transparent nature can support you at every stage of your SI manufacturing journey.
When bringing high-quality, safe and efficacious therapies to patients, time is life and expertise is key. In this article, Thomas P Wilson, Contract Manufacturing Lead at Pfizer CentreOne, shares how you can find the right partner to help you secure an efficient and dependable API and biological drug substance supply chain and ultimately deliver your therapies to patients in need.
In this 1-pager, we address the complex challenges of pharmaceutical supply chains and explore the need for tailored, adaptable solutions that prioritize transparency and risk mitigation to ensure a resilient supply chain for the secure delivery of your critical therapies.
In the latest Pharma Matters podcast episode, Thomas P Wilson, Global Contract Manufacturing Leader at Pfizer CentreOne, shares his expert insights on supply chain management, discussing the importance of rigorous supplier selection and emphasizing the strategies needed to help ensure a resilient supply chain.
In the dynamic landscape of pharmaceutical outsourcing, Rick L. Knight, Global Head, Strategic Account Management at Pfizer CentreOne, reveals how biotech and pharma companies are increasingly turning to contract development and manufacturing organizations (CDMOs) for support in overcoming capacity constraints, accessing specialized expertise and accelerating time-to-market.
In this one-pager, we share insights into how integrated CDMOs are helping companies like yours overcome current drug development and manufacturing challenges.
In a recent podcast with Contract Pharma, Rick L. Knight Global Head, Strategic Account Management at Pfizer CentreOne, shares insights into how integrated CDMOs are helping companies like yours overcome current drug development and manufacturing challenges.
High-speed, high-quality production might seem like an unrealistic utopia, but it is achievable when it strictly adheres to a number of core principles. Alongside these non-negotiables, the people behind the process, the environment in which they operate, and the tools at their disposal must be world-class. Find out more in this article.
The generally accepted principle is that moving faster means more corners cut or less rigor applied. But this one-pager explores why, with the right processes and people in place, that isn’t the case. Our Lightspeed Approach, for example, is a robust, proven and meticulous methodology that has delivered tangible results for clients and patients. With top-tier expertise and resources, we’re able to accelerate your route to market without compromise.
In this podcast, Jim Donovan, Vice President for Pfizer CentreOne, explores the concept of expedited development in high-pressure situations, and how the lessons learned can help to optimize sterile injectable development processes to meet rising demand.
Uncover unique insights from global Pfizer OSD scientists and manufacturing experts on the
challenges facing your journey to market.
Discover how to navigate these complexities with confidence to bring your product to patients
on time, without delay.